COVID-19 vaccination in Spain

Last updated
COVID-19 vaccination in Spain
2020 12 27 primera profesional vacunada 2.jpg
Asturian residential home worker ready to get the COVID-19 vaccine
DateDecember 27, 2020 (2020-12-27) – present
Duration11 months and 6 days
Location Spain
Cause COVID-19 pandemic in Spain
TargetAdult population (age 12+)
Organised by Ministry of Health
Participants38.409.145 people
Outcome80,9% partially vaccinated (1 of 2 doses)
79,4% fully vaccinated [1]
Website COVID-19 Vaccination Strategy
Updated in December 3, 2021

The COVID-19 vaccination in Spain is the national vaccination strategy started on the 27th of December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.

Contents

As of November 23, 2021, the following doses had been received: 59,296,575 Pfizer–BioNTech COVID-19 vaccine doses, 16,105,300 Moderna vaccine doses, 17,427,500 Oxford–AstraZeneca vaccine doses and 2,659,000 Janssen vaccine doses, totaling to 95,488,375 doses. Out of these doses, 75,173,640 had been administered.

The autonomous communities with the highest fully-vaccinated percentage are Asturias (85.1%) and Galicia (84.9%), while the communities with the lowest percentage are the Canary Islands (75.7%) and the Balearic Islands (72.4%). The Spanish average percentage was 79.1%, amounting to 37,557,243 people.

Out of the total, 3,776,118 have been administered as additional doses, or third doses, of which 3,319,229 are Pfizer–BioNTech COVID-19 vaccine doses and 456,889 are Moderna vaccine doses.

The amount of doses ordered from Q1 to Q4 of 2021 is 141,943,261.

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

VaccineDoses orderedApprovalDeploymentAge Applied [2]
Pfizer–BioNTech 146 millionGreen check.svg 21 December 2020Green check.svg 27 December 202012+
Moderna 52 millionGreen check.svg 6 January 2021Green check.svg 12 January 202112+
Oxford-AstraZeneca 31 millionGreen check.svg 29 January 2021Green check.svg 7 February 202160–69
Janssen 20 millionGreen check.svg 11 March 2021Green check.svg 5 May 202140+
Novavax 2,2 millionPendingPendingPending
CureVac PendingPendingPendingPending
Valneva PendingPendingPendingPending
Sanofi–GSK PendingPendingPendingPending

Phases and development of the vaccination campaign

According to the Government of Spain, the vaccination campaign, which is being carried out voluntarily, is structured in four phases. These phases are at the same time formed by different population groups defined in the National COVID-19 Vaccination Strategy : [3]

PhasesPopulation groupDevelopment [lower-alpha 1]
1st doses2nd doses [lower-alpha 2]
0Development, approval and assessment.
1Priority groupsElderly and disabled care homes' residents and staffCompleted (99,3%) [lower-alpha 3] Completed (92,0%) [lower-alpha 3]
First line health and socio-sanitary professionalsCompletedCompleted
Other health and socio-sanitary professionalsCompletedCompleted
Highly dependent people not living in care homesCompletedCompleted
2

(In progress)

Other priority groupsAll those aged 80 and older>100,0% [lower-alpha 4] >100,0% [lower-alpha 4]
All those aged between 70 and 79 and those with very high risk conditions99,1% [lower-alpha 5] 98,2% [lower-alpha 5]
All those aged between 60 and 6997,9%95,1%
Other health and socio-sanitary professionalsCompletedCompleted
Workers with an essential social roleCompletedCompleted
All those aged between 50 and 5997,4%93,1%
3

(In progress)

Rest of priority groupsAll those aged between 40 and 4988,9%85,6%
All those aged between 30 and 3974,4%72,7%
All those aged between 20 and 2973,0%70,0%
All those aged between 12 and 1980,7%77,2%
TOTALS
Current prioritary goal (all those aged 40 and over)94,2%92,1%
Target population (all those aged 12 and over)90,8%85,5%
Spanish total population79,5%77,3%

Notes: The information shown in the table is collected up to September 1, 2021.

  1. When a group is classified as "completed", this is done based on the data reflected on the Sixth Edition of the National COVID-19 Vaccination Strategy and the Ministry of Health reports. Obviously, new incorporations to priority groups, as well as people who decide to change their initial position about receiving the vaccine, may not fulfill this classification.
  2. When vaccinated, those who receive the Janssen vaccine, which requires just a single dose, are counted both in first and second doses.
  3. 1 2 Weekly updates are made available by the Ministry of Health about the vaccination index among those living in care homes (residents of elderly and disabled nursing homes). The difference between 100% and the current index is due to new residents, who are vaccinated when they move to these centres.
  4. 1 2 The index is higher than 100%, since the census used for its computation is the most recent one prepared by the National Statistics Institute (INE), which may be a bit outdated, since it was elaborated in 2020. [4]
  5. 1 2 The vaccination index of this priority group is referred to those aged between 70 and 79 years old. It does not include those who have very high risk conditions for their health. However, the current National Strategy determines that their vaccination must be carried out at the same time for both groups, so it is expected that the vaccination index among those with risk conditions is quite similar or higher.

Public opinion

Centre for Sociological Research

According to the Centre for Sociological Research, the Spanish public organism in charge of investigating the public opinion of the society on many different topics, these are the data of the acceptance of the vaccine among the Spanish population:

Question: "Would you be willing to get vaccinated immediately when the vaccine is available?"
Oct 2020Nov 2020Dec 2020Jan 2021Feb 2021Mar 2021Apr 2021May 2021Jun 2021
YESYes40,2%36,8%40,5%72,5%82,9%82,5%70,4%53,2%37,8%
They are already vaccinated5,1%15,0%37,7%55,1%
Yes, depending on the origin of the vaccine0,2%0,1%0,6%0,2%0,4%0,6%2,4%1,2%0,4%
Yes, if there are guarantees, if it is proven, if it is reliable2,2%1,4%16,2%2,5%1,8%0,9%1,6%0,5%0,2%
Yes, on the advice of the authorities, scientists or health professionals0,2%0,3%3,6%1,3%0,9%0,3%0,4%0,3%0,1%
Yes, if there is enough information0,2%0,0%3,2%0,8%0,4%0,2%0,3%0,2%0,1%
TOTAL YES43,0%38,6%64,1%77,3%86,4%89,6%90,1%93,1%93,7%
NONo43,8%47,0%28,0%16,5%6,5%5,4%5,3%3,7%3,6%
TOTAL NO43,8%47,0%28,0%16,5%6,5%5,4%5,3%3,7%3,6%
NK

+

NA

Does not know, doubts12,4%13,4%5,3%4,5%5,5%3,8%3,3%2,4%1,8%
Other answers0,6%0,7%2,5%1,7%1,6%1,0%1,3%0,7%0,6%
N.A. (Not answers)0,4%0,3%0,1%0,1%0,1%0,0%0,1%0,0%0,1%
TOTAL NK/NA (OTHER ANSWERS)13,4%14,4%7,9%6,3%7,2%4,8%4,7%3,1%2,5%
Sample2.9243.8533.8173.8523.8693.8203.8233.8143.814
Reference [5] [6] [7] [8] [9] [10] [11] [12] [13]

From February 2021 onwards, the centre began to ask among those who did not want to take the vaccine about the reasons they had for choosing not to receive the shot, obtaining the following results:

[ONLY AMONG THOSE WHO ARE NOT WILLING TO BE VACCINATED WHEN AVAILABLE FOR THEM]: "What is the main reason you have by which you would not take the vaccine when your turn comes?" (spontaneous answer)
February 2021March 2021April 2021May 2021June 2021
% question% total sample% question% total sample% question% total sample% question% total sample% question% total sample
They do not rely on these vaccines31,2%2,0280%29,3%1,5822%34,6%1,8338%25,3%0,9361%35,4%1,2744%
Because of fear to develop risks for their health/side-collateral effects18,5%1,2025%20,1%1,0854%25,3%1,3409%25,3%0,9361%15,6%0,5616%
They are against all vaccines in general4,3%0,2795%1,7%0,0981%3,1%0,1643%4,4%0,1628%7,1%0,2556%
They prefer to wait to see how they work9,2%0,5980%6,0%0,3240%3,5%0,1855%7,7%0,2849%6,9%0,2484%
They do not believe they are effective8,3%0,5395%7,1%0,3834%5,2%0,2756%8,7%0,3219%5,2%0,1872%
They do not consider it necessary (without specifying)4,6%0,2484%3,7%0,1961%7,3%0,2701%4,7%0,1692%
Because of lack of guarantees: few trials, earliness, lack of analysis4,6%0,2990%4,6%0,2484%3,7%0,1961%4,2%0,1554%3,1%0,1116%
COVID-19 denial3,1%0,1674%2,8%0,1484%0,7%0,0259%3,1%0,1116%
Because of having few possibilities of infection3,2%0,2080%3,5%0,1890%1,0%0,0530%4,8%0,1776%3,0%0,1080%
Because of having allergies, other diseases or treatments, breastfeeding, pregnancy3,0%0,1950%2,1%0,1134%3,6%0,1908%3,7%0,1369%2,3%0,0828%
Because of having passed COVID-194,6%0,2484%3,4%0,1802%0,2%0,0074%2,2%0,0792%
Because of lack of information1,5%0,0975%3,7%0,1998%1,1%0,0583%0,7%0,0259%1,4%0,0504%
There are other people more vulnerable or with a higher risk than them0,8%0,052%1,0%0,0540%0,8%0,0288%
They do not ever get vaccinated1,0%0,0650%1,5%0,0810%1,6%0,0848%1,5%0,0555%--
Because of any other reason12,9%0,8385%4,9%0,2646%5,8%0,3074%3,1%0,1147%7,3%0,2628%
They do not know, doubt1,3%0,0845%1,9%0,1026%1,0%0,0530%1,8%0,0666%--
N.A. (Not answers)0,2%0,0130%0,5%0,0265%0,8%0,0296%1,9%0,0684%
Sample2513.8692083.8202033.8231433.8141383.814
Reference [9] [10] [11] [12] [13]

Vaccinated Spanish public figures

The progress of the vaccination campaign to more and more demographic groups has allowed many public figures to receive one or two doses of the vaccine correspondent to them by age or belonging to some other priority group.

Politicians

State authorities

  • King Phillip VI of Spain received the vaccine on May 29, 2021, at 53 years old. The head of State received the vaccine without medical transcendence, and was only informed after receiving the jab. He was vaccinated once the access for his age group was opened, at the massive vaccination point set up in WiZink Center in Madrid, as any other citizen. He was accompanied by the head of the Royal Family medical service, Juan Martínez, and by the Vice-councillor for Public Health and COVID-19 Plan of the Community of Madrid, Antonio Zapatero. Regarding the vaccine brand, although it was not officially communicated, it is known that only Janssen vaccines were given that day. With respect to the published images, these were not distributed by the Royal Family, however, the TV programme Cuatro al día from the Spanish broadcasting station Cuatro published a picture of the head of State receiving the vaccine.

Related Research Articles

The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. As part of the Department of Health, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.

COVID-19 pandemic in Uruguay Ongoing COVID-19 viral pandemic in Uruguay

The COVID-19 pandemic in Uruguay is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first cases in Uruguay were reported on 13 March 2020 by the Ministry of Public Health. The early cases were imported from Italy and Spain, with some local transmissions.

COVID-19 vaccination in the United Kingdom Immunisation against COVID-19

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom. The UK's vaccination rollout was the world's first mass immunisation programme for the disease when it began on 8 December 2020 after Margaret Keenan received her first dose of two. As of 6 October 2021, 49,068,705 first doses and 45,078,529 second doses of a vaccine had been administered across the UK.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Israel

Israel's COVID-19 vaccination programme, officially named "Give a Shoulder", began on 19 December 2020, and has been praised for its speed, having given twenty percent of the Israeli population the first dose of the vaccines' two dose regimen in the span of three weeks.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

COVID-19 vaccination in the Republic of Ireland Immunisation plan against COVID-19

The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and was ranked number one in the European Union in terms of its percentage of adult population fully vaccinated.

COVID-19 vaccination in Canada COVID-19 vaccination programme in Canada

COVID-19 vaccination in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Provinces have worked with local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. The vaccination effort began December 14, 2020 and is currently ongoing.

COVID-19 vaccination in South Africa Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the United States Plan to immunize against COVID-19

The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020; mass vaccinations began on December 14, 2020. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen vaccine was granted emergency use authorization on February 27, 2021. By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in New Zealand Ongoing COVID-19 vaccine programme in New Zealand

COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the year with the goal of vaccinating all willing New Zealanders aged 12+. As of 1 September, anyone in New Zealand is eligible to be vaccinated.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination campaign in Quebec is an ongoing provincial effort to distribute and administer the vaccine against COVID-19.

COVID-19 vaccination in Singapore Plan to immunize against COVID-19

COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Brazil

The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.

COVID-19 vaccination in Taiwan Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

References

  1. https://www.vacunacovid.gob.es/
  2. "Calendario de vacunas: llega la hora de los treintañeros y el Zendal se estrena de madrugada con más de mil pinchazos..." www.20minutos.es – Últimas Noticias. June 28, 2021.
  3. "¿Es obligatorio vacunarse contra el COVID-19?". Gobierno de España (in Spanish). 2020-12-27. Retrieved 2021-02-14.
  4. "Población por comunidades, edad (año a año), Españoles/Extranjeros, Sexo y Año". INE (in Spanish). Retrieved 2021-05-06.
  5. "CIS Barómetro" (PDF). October 2020.
  6. "CIS Barómetro" (PDF). November 2020.
  7. "CIS Barómetro" (PDF). December 2020.
  8. "CIS Barómetro" (PDF). January 2021.
  9. 1 2 "CIS Barómetro" (PDF). February 2021.
  10. 1 2 "CIS Barómetro" (PDF). March 2021.
  11. 1 2 "CIS Barómetro (Avance)" (PDF). April 2021.
  12. 1 2 "CIS Barómetro (Avance)" (PDF). May 2021.
  13. 1 2 "CIS Barómetro (Avance)" (PDF). June 2021.